A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis. - Maersk-Moller C; Pontieri L; Stilund MLM; Christensen JR; Storr LK; Hansen V; Schäfer J; Weglewski A; Romani KQ; Jensen HB; Illes Z; Papp V; et al. (European journal of neurology, 2026)